#Spain #Barcelona #Probiotics #Vitafoods #BioFlag

BioFlag's Innovative Probiotic Solutions at Vitafoods Europe 2025

BioFlag Co., Ltd., a leading probiotic company based in China, proudly showcased its advanced probiotic solutions at the prestigious Vitafoods Europe 2025 event held in Barcelona, Spain. The company attracted considerable global media attention with its range of scientifically validated functional probiotics designed to address various health concerns.

During the exhibition, BioFlag highlighted its cutting-edge products, which include clinically tested probiotic strains and ready-to-use probiotic items that target intestinal health, immune regulation, metabolic wellness, weight management, oral care, and emotional well-being. Each product reflects the company’s commitment to meeting strict European and American standards.

Among the notable innovations presented were:

1. Bifidobacterium animalis subsp. lactis BL-99 - Originating from BioFlag’s extensive library of maternal and infant probiotic strains in China, BL-99 boasts 12 Chinese invention patents related to intestinal health, immune regulation, and bone health. This strain has found widespread use in infant formulas, yogurt, and dietary supplements.
2. Lactobacillus paracasei K56 - Isolated from the intestines of healthy Chinese infants, this strain has demonstrated clinical efficacy in reducing body fat, visceral fat, and waist circumference. It is supported by 12 published research studies and has been awarded 9 Chinese invention patents.
3. Bifidobacterium animalis subsp. Lactis CP-9 - Derived from the breast milk of healthy Chinese mothers, this patented strain is recognized for its effects in combating obesity and treating or preventing jaundice.

As a representative of China's probiotic industry, BioFlag has established itself as a comprehensive player across the entire supply chain. The company’s assets include:

• - A unique library with over 3,500 probiotic strains and thirty functional screening platforms.
• - More than 130 granted patents and over 100 published scientific articles.
• - International certifications, including GMP, FSSC22000, and HALAL.
• - A versatile production capability encompassing powders, tablets, capsules, and various pharmaceutical forms.

During the event, BioFlag successfully signed cooperation agreements with numerous companies and institutions across Europe, North America, and other regions. A company spokesperson stated, “With nearly two decades of expertise in functional probiotics, we are dedicated to advancing R&D innovation and smart manufacturing to provide superior health solutions to our global clients.”

For more information about BioFlag’s products and innovations, visit their official website at BioFlag’s website. This presentation at Vitafoods Europe 2025 marks a significant stepping stone in BioFlag’s mission to elevate health and wellness through probiotic science.